Bruce A Peterson, Clara D. Bloomfield

Research output: Contribution to journalArticlepeer-review

43 Scopus citations


Maintenance chemotherapy consisting of weekly oral 6-thioguanine and intramuscular cytosine arabinoside was administered to 24 adult patients with acute non-lymphocytic leukæmia in complete remission. The median duration of complete remission was 16.5 months, with 9 patients (38%) still in their first remission after 18-56 months. 33% of the patients have been in continuous remission for over 2 yr, 21% for over 3 yr, and 12.5% for over 4 yr. Median survival so far is 22.5 months. This maintenance regimen is well tolerated, is easily administered on an outpatient basis, and produces substantial numbers of long-term remissions.

Original languageEnglish (US)
Pages (from-to)158-160
Number of pages3
JournalThe Lancet
Issue number8030
StatePublished - Jul 23 1977

Bibliographical note

Funding Information:
and Prof. A. Pinchera for helpful criticism. The National Pituitary Agency and the National Institute of Arthritis and Metabolic Diseases (U.S.A.) supplied human T.s.H. and T.S.H. antiserum, and Dr J. T. Visser (Rotterdam) provided us with specific T3 antiserum. The study was supported by grants from the Finnish Academy to M.J.K. and by a grant from the Red Heart Foundation of the Finnish Lion’s Organi- sation. The work was aided by research grants to A. K. from the U.S. Heart Association.National Heart and Lung Institute (HE04697) and the American


Dive into the research topics of 'PROLONGED MAINTAINED REMISSIONS OF ADULT ACUTE NON-LYMPHOCYTIC LEUKAEMIA'. Together they form a unique fingerprint.

Cite this